Artificial Intelligence in Drug Discovery Market
Artificial Intelligence in Drug Discovery Market - Global Industry Assessment & Forecast
#
Pages:
175
Base Year:
2022
Feb - 2022
Format:
Report Code:
VMR-1239
Segments Covered
By
Application Drug Optimization and Repurposing, Preclinical Testing, Others
-
By
Therapeutic Look Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others
-
By
Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 885.32 Million |
 Revenue 2030:
|
USD 13988.71 Million |
 Revenue CAGR
(2023 - 2030): |
41.20% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Artificial Intelligence in Drug Discovery Market Segment Analysis
- Artificial Intelligence in Drug Discovery Application Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Artificial Intelligence in Drug Discovery Therapeutic Look Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
-
North America Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- U.S.
- U.S. Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- U.S. Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- U.S. Artificial Intelligence in Drug Discovery Market, by Application
- Canada
- Canada Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Canada Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Canada Artificial Intelligence in Drug Discovery Market, by Application
-
Mexico
- Mexico Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Mexico Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Mexico Artificial Intelligence in Drug Discovery Market, by Application
-
North America Artificial Intelligence in Drug Discovery Market, by Application
- Europe
-
Europe Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
-
Europe Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- U. K.
- U.K. Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- U.K. Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- U.K. Artificial Intelligence in Drug Discovery Market, by Application
- France
- France Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- France Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- France Artificial Intelligence in Drug Discovery Market, by Application
-
Germany
- Germany Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Germany Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Germany Artificial Intelligence in Drug Discovery Market, by Application
-
Italy
- Italy Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Italy Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Italy Artificial Intelligence in Drug Discovery Market, by Application
-
Spain
- Spain Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Spain Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Spain Artificial Intelligence in Drug Discovery Market, by Application
-
Rest of Europe
- Rest of Europe Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Rest of Europe Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Rest of Europe Artificial Intelligence in Drug Discovery Market, by Application
-
Europe Artificial Intelligence in Drug Discovery Market, by Application
- Asia Pacific
-
Asia Pacific Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
-
Asia Pacific Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- China
- China Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- China Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- China Artificial Intelligence in Drug Discovery Market, by Application
- Japan
- Japan Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Japan Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Japan Artificial Intelligence in Drug Discovery Market, by Application
-
Germany
- Germany Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Germany Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Germany Artificial Intelligence in Drug Discovery Market, by Application
-
India
- India Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- India Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- India Artificial Intelligence in Drug Discovery Market, by Application
-
South Korea
- South Korea Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- South Korea Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- South Korea Artificial Intelligence in Drug Discovery Market, by Application
-
South East Asia
- South East Asia Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- South East Asia Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- South East Asia Artificial Intelligence in Drug Discovery Market, by Application
-
Rest of Asia Pacific
- Rest of Asia Pacific Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Rest of Asia Pacific Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Rest of Asia Pacific Artificial Intelligence in Drug Discovery Market, by Application
-
Asia Pacific Artificial Intelligence in Drug Discovery Market, by Application
- Latin America
-
Latin America Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
-
Latin America Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Brazil
- Brazil Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Brazil Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Brazil Artificial Intelligence in Drug Discovery Market, by Application
- Argentina
- Argentina Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Argentina Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Argentina Artificial Intelligence in Drug Discovery Market, by Application
-
Rest of Latin America
- Rest of Latin America Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Rest of Latin America Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Rest of Latin America Artificial Intelligence in Drug Discovery Market, by Application
-
Latin America Artificial Intelligence in Drug Discovery Market, by Application
- Middle East & Africa
-
Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
-
Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- GCC Countries
- GCC Countries Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- GCC Countries Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- GCC Countries Artificial Intelligence in Drug Discovery Market, by Application
- South Africa
- South Africa Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- South Africa Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- South Africa Artificial Intelligence in Drug Discovery Market, by Application
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Application
- Drug Optimization and Repurposing
- Preclinical Testing
- Others
- Rest of Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- Metabolic Diseases
- Infectious Disease
- Others
- Rest of Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Application
-
Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Application
- North America
Vantage Market
Research | 24-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Artificial Intelligence in Drug Discovery in terms of revenue?
-
The global Artificial Intelligence in Drug Discovery valued at USD 885.32 Million in 2022 and is expected to reach USD 13988.71 Million in 2030 growing at a CAGR of 41.20%.
Which are the prominent players in the market?
-
The prominent players in the market are IBM Corporation (US), Microsoft (US), and Google (US), NVIDIA Corporation (US), Atomwise, Inc. (US), Deep Genomics (Canada), Cloud Pharmaceuticals (US), Insilico Medicine (US), BenevolentAI (UK), Exscientia (UK), Cyclica (Canada), BIOAGE (US), Numerate (US), NuMedii (US), Envisagenics (US), twoXAR (US), OWKIN, Inc. (US), XtalPi (US), Verge Genomics (US), and BERG LLC (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 41.20% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Artificial Intelligence in Drug Discovery include
- Increasing Demand for Artificial Intelligence in Drug Discovery
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Artificial Intelligence in Drug Discovery in 2022.
